The changes in FIGO staging for carcinoma of the cervix uteri.
Ceska Gynekol
; 84(3): 216-221, 2019.
Article
in En
| MEDLINE
| ID: mdl-31324113
ABSTRACT
INTRODUCTION:
The carcinoma of the cervix uteri is the fourth most common cancer in women worldwide and more than 85% of these cases occur in developing countries. Altogether 822 new cases were found in the Czech Republic during 2016 which means the incidence 15,3 new diseases/100,000 women.OBJECTIVE:
To provide an overview of changes in FIGO (International Federation of Gynecology and Obstetrics) staging for carcinoma of the cervix uteri with an incorporation of possible imaging methods and/or pathological findings, and clinical assessment of tumor size and extent. SETTINGS Gynecologic Oncology Center, Department of Gynecology and Obstetrics, Hospital Na Bulovce and 1st Medical School of Charles University, Prague; Gynecologic Oncology Center, Department of Gynecology and Obstetrics, General Faculty Hospital and 1st Medical School of Charles University, Prague; Institute of Radiation Oncology, Hospital Na Bulovce, Prague.METHODS:
For this review, we have used the results of studies, review articles, and guidelines of oncogynecologic organisations on the cervical cancer published in English. They were identified through a search of literature using PubMed, MEDLINE-Ovid, Scopus and Cochrane Library with the keywords. We summarize the new classification, main changes compared to the former one and their clinical impact.CONCLUSION:
Lateral extension measurement is removed in the stage IA, the only criterion is the measured deepest invasion.Key words
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma
/
Uterine Cervical Neoplasms
/
Cervix Uteri
/
Lymphatic Metastasis
/
Neoplasm Staging
Type of study:
Guideline
/
Prognostic_studies
Limits:
Female
/
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Ceska Gynekol
Journal subject:
GINECOLOGIA
Year:
2019
Document type:
Article